While there are many studies focusing on the mechanism underlying the HIF2α-dependent promotion of ccRCC progression, studies regarding the mechanism of how HIF1α inhibits tumors are insufficient. This evidence concerns the gene HIF1A and nonpapillary renal cell carcinoma.